Methadone and buprenorphine for the management of opioid dependence (TA114)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 January 2007
Naltrexone for the management of opioid dependence (TA115)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 January 2007